1. Home
  2. CCIX vs CADL Comparison

CCIX vs CADL Comparison

Compare CCIX & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCIX
  • CADL
  • Stock Information
  • Founded
  • CCIX 2023
  • CADL 1999
  • Country
  • CCIX United States
  • CADL United States
  • Employees
  • CCIX N/A
  • CADL N/A
  • Industry
  • CCIX
  • CADL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCIX
  • CADL Health Care
  • Exchange
  • CCIX Nasdaq
  • CADL Nasdaq
  • Market Cap
  • CCIX 381.7M
  • CADL 306.4M
  • IPO Year
  • CCIX 2024
  • CADL 2021
  • Fundamental
  • Price
  • CCIX $10.56
  • CADL $11.63
  • Analyst Decision
  • CCIX
  • CADL Strong Buy
  • Analyst Count
  • CCIX 0
  • CADL 4
  • Target Price
  • CCIX N/A
  • CADL $19.75
  • AVG Volume (30 Days)
  • CCIX 30.3K
  • CADL 1.2M
  • Earning Date
  • CCIX 11-07-2013
  • CADL 03-27-2025
  • Dividend Yield
  • CCIX N/A
  • CADL N/A
  • EPS Growth
  • CCIX N/A
  • CADL N/A
  • EPS
  • CCIX N/A
  • CADL N/A
  • Revenue
  • CCIX N/A
  • CADL N/A
  • Revenue This Year
  • CCIX N/A
  • CADL N/A
  • Revenue Next Year
  • CCIX N/A
  • CADL N/A
  • P/E Ratio
  • CCIX N/A
  • CADL N/A
  • Revenue Growth
  • CCIX N/A
  • CADL N/A
  • 52 Week Low
  • CCIX $10.00
  • CADL $1.34
  • 52 Week High
  • CCIX $11.17
  • CADL $14.60
  • Technical
  • Relative Strength Index (RSI)
  • CCIX N/A
  • CADL 72.95
  • Support Level
  • CCIX N/A
  • CADL $8.11
  • Resistance Level
  • CCIX N/A
  • CADL $13.68
  • Average True Range (ATR)
  • CCIX 0.00
  • CADL 0.78
  • MACD
  • CCIX 0.00
  • CADL 0.42
  • Stochastic Oscillator
  • CCIX 0.00
  • CADL 70.29

About CCIX Churchill Capital Corp IX Ordinary Shares

Churchill Capital Corp IX is a blank check company.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: